
MCHPP · Nasdaq
The supplied consensus panel records zero analysts and no low, mean, or high price target, so it establishes neither a consensus rating nor a target cluster or spread for MCHPP. The evidence does not identify a most- or least-bullish analyst, named MCHPP coverage, or target revisions during the week. A separate AInvest excerpt mentions Truist’s Underperform rating and an $87.50 median target against about $65 for MCHP, but frames that upside as an indirect benefit to MCHP and does not establish an MCHPP rating action. Those figures therefore cannot be used to describe MCHPP analyst views.